Conditional Approval Pathways for Unmet Needs
Conditional Approval Pathways for Unmet Needs How Conditional Approvals Accelerate Therapies for Unmet Rare Disease Needs Understanding the Concept of Conditional Approval In the context of rare and life-threatening diseases, traditional drug approval processes—requiring full clinical trial data—may delay patient access to critical therapies. Regulatory agencies such as the European Medicines Agency (EMA) and the…